Press Releases

GlobeNewswire, Inc.

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease, having met the primary endpoint, reductions in lesion growth rate, in the pivotal, global Phase 3 DRAGON trial Company recently initiated a...

EIN Presswire

NEW YORK, NY, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- The American Swiss Foundation (ASF) hosted its 81st Annual Gala on Tuesday, May 12th, at the Harvard Club in New York City, honoring Andreas Berger, Group Chief Executive Officer of...

GlobeNewswire, Inc.

Key highlights from the first quarter of operations under the expanded management team include the following: Anticipated FDA decision on the Company's ANDA for Preservative-Free Ketamine in Q3 2026, with favorable preliminary determinations...

EIN Presswire

GENEVA, SWITZERLAND, May 18, 2026 /⁨EINPresswire.com⁩/ -- King Faisal Specialist Hospital & Research Centre (KFSH) will participate in the World Economic Forum Annual Health Roundtable 2026, taking place on Tuesday, May 19, during the session “AI...

GlobeNewswire, Inc.

LEXINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (“Rapid Micro Biosystems”) (Nasdaq: RPID), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient...

ECB - European Central Bank

Summary At its meeting on 30 April 2026, the Governing Council decided to keep the three key ECB interest rates unchanged.

GlobeNewswire, Inc.

Completed Formal Dispute Resolution Meeting with FDA regarding Complete Response Letter (CRL) for ONS-5010; Decision Expected This Month Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe with Commercial Distribution Agreement with...

EIN Presswire

“Assetization: Inside the Trillion-Dollar Investing Revolution”, published by Wiley, now available in bookstores.

GlobeNewswire, Inc.

Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care Geneva, Switzerland, May 15, 2026 - The Davos Alzheimer’s Collaborative (DAC), a worldwide...

GlobeNewswire, Inc.

WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today...

EIN Presswire

Report evaluates twenty Asian-built AI-IoT vendors, features ten across India, China, Singapore, and Japan.

Bank of England

1: Executive Summary Rapid innovation is driving a shift towards fast, resilient and always‑on payments.

GlobeNewswire, Inc.

Reports first quarter 2026 total revenue of $8.0 million, representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first quarter of 2025 First quarter 2026...

GlobeNewswire, Inc.

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents, restricted cash and capital commitments...

GlobeNewswire, Inc.

LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- Outdoor Innovation, the industry’s most robust recognition platform for the innovators and leaders of the Outdoor and Sports Recreation Industry, today announced that PROVUU, makers of outdoor wearable...

GlobeNewswire, Inc.

DOVER, Del., May 13, 2026 (GLOBE NEWSWIRE) -- Arcanis (arcanis.com), a decision surface infrastructure company for late-stage private companies, today published two research papers laying out a market-structure thesis: the late-stage private...

GlobeNewswire, Inc.

ZÜRICH, Switzerland, May 12, 2026 (GLOBE NEWSWIRE) -- Emerald Technology Ventures, a globally recognized venture capital firm focused on industrial innovation, has announced Mitsui Kinzoku as a new limited partner in its Industrial Innovation...

GlobeNewswire, Inc.

Lead Radio-DARPin MP0712 progressing in Phase 1/2a trial with multiple clinical sites opening and initial clinical data expected in 2026 New data on Radio-DARPins’ amenability to range of therapeutic payloads enable isotope-agnostic strategy for...

GlobeNewswire, Inc.

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026 Timeline for submission of NDA of deucrictibant IR for the on-demand treatment of HAE attacks remains on-track in...

GlobeNewswire, Inc.

An Innovation Powerhouse: The initiative unites world-class experts in FoodTech, pet care, and ingredients to accelerate the transition toward a more sustainable pet food supply chain.